Related Experiment Video
Updated: Jul 16, 2026
09:50
Experimental Methods for Testing the Effects of Neurotrophic Peptide, ADNF-9, Against Alcohol-induced Apoptosis during Pregnancy in C57BL/6 Mice
Published on: April 24, 2013
A femtomolar-acting neuroprotective peptide
1Laboratory of Developmental Neurobiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892-4480, USA.
The Journal of Clinical Investigation
|May 15, 1996
Summary
A novel peptide derived from glial cells shows potent neuroprotection against various neuronal insults. This discovery offers a promising avenue for treating neurodegenerative diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Neurodegenerative diseases pose significant challenges due to limited treatment options.
- Identifying novel neuroprotective agents is crucial for therapeutic development.
- Extracellular stress-related proteins with neuroprotective functions are increasingly recognized.
Purpose of the Study:
- To identify and characterize a novel neuroprotective protein secreted by astroglial cells.
- To isolate and synthesize a peptide derived from this protein with potent neuroprotective activity.
- To investigate the potential of this peptide in preventing neuronal cell death.
Main Methods:
- Isolation of a neurotrophic protein using sequential chromatography (ion exchange, size exclusion, hydrophobic interaction).
- Characterization of the protein's molecular mass and isoelectric point.
- Peptide sequencing and synthesis of a 14-amino acid peptide.
- Testing the peptide's neuroprotective effects against HIV envelope protein (GP 120), N-methyl d-aspartate, beta-amyloid peptide, and tetrodotoxin.
- Investigating the role of extracellular stress-like proteins using heat shock protein 60 antiserum.
Main Results:
- A novel 14-amino acid peptide, homologous to heat shock protein 60, demonstrated significant neuroprotection.
- The peptide prevented neuronal death induced by HIV GP 120, excitotoxicity, beta-amyloid, and electrical blockade.
- The identified protein, activity-dependent neurotrophic factor, and its derived peptide show promise in preclinical models.
- Evidence suggests the existence of extracellular stress-like proteins with neuroprotective capabilities.
Conclusions:
- A potent neuroprotective glial protein and its active peptide have been identified.
- This discovery provides a foundation for developing novel therapeutic strategies for neurodegenerative diseases.
- The findings highlight the therapeutic potential of targeting extracellular stress-response pathways in neuronal protection.
